Urinary tract infection in adults: gaps in current guidelines - opinions from an international multidisciplinary panel and relevance to clinical practice.

Q2 Biochemistry, Genetics and Molecular Biology
Kalpana Gupta, Florian Wagenlehner, Mark Wilcox, Sonali D Advani, Manu Bilsen, Gernot Bonkat, Rafael Cantón, Suzanne Geerlings, Beatrice Grabein, Juan P Horcajada, Pamela Kushner, Navaneeth Narayanan, Marc Scheetz
{"title":"Urinary tract infection in adults: gaps in current guidelines - opinions from an international multidisciplinary panel and relevance to clinical practice.","authors":"Kalpana Gupta, Florian Wagenlehner, Mark Wilcox, Sonali D Advani, Manu Bilsen, Gernot Bonkat, Rafael Cantón, Suzanne Geerlings, Beatrice Grabein, Juan P Horcajada, Pamela Kushner, Navaneeth Narayanan, Marc Scheetz","doi":"10.1186/s12919-025-00333-5","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Although urinary tract infections (UTIs) are one of the most common infections encountered in clinical practice, many challenges remain with respect to classification and management. The purpose of this report is to discuss key issues in the management of UTIs and identify gaps in current knowledge and guidelines, as well as future research needs.</p><p><strong>Design: </strong>A multidisciplinary panel of 13 experts from 6 European countries and the United States met on April 27, 2024. They discussed predefined key clinical questions, including classification of UTIs, current management guidelines, management of UTIs in men, antimicrobial switching, and post-treatment asymptomatic bacteriuria.</p><p><strong>Results: </strong>The panel agreed that differentiation between complicated and uncomplicated UTIs is crucial to antimicrobial selection and can impact outcomes. In particular, definitions of complicated UTIs (cUTIs) vary widely between guidelines and in the literature. Patients with cUTIs are not a homogeneous group and differences in risk factors and prognosis should be considered. However, a balance must be sought between appropriate antimicrobial treatment and complexity of guidelines, which can hinder their implementation, especially in primary care. Guidelines published by the European Urology Association and the Infectious Diseases Society of America differ in their antimicrobial treatment recommendations for cUTIs, which is important at a time of increasing antimicrobial resistance. In men with UTIs, it has been established that a longer duration of antimicrobial therapy is needed in cases where fever is present. De-escalation from broad- to narrow-spectrum antimicrobials is recommended wherever possible, and is associated with similar outcomes in many patients relative to remaining on broad-spectrum treatment. Post-treatment asymptomatic bacteriuria should not be assessed, and treatment is not recommended. Non-specialist physician education is crucial to achieving better outcomes for patients with UTIs.</p><p><strong>Implications: </strong>Many challenges remain in the management of UTIs in adults, most notably making an accurate classification, which drives antimicrobial treatment selection. A balance between adequacy of management guidelines and their uptake in routine clinical practice is needed to improve outcomes.</p>","PeriodicalId":9046,"journal":{"name":"BMC Proceedings","volume":"19 Suppl 16","pages":"18"},"PeriodicalIF":0.0000,"publicationDate":"2025-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12224355/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Proceedings","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s12919-025-00333-5","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: Although urinary tract infections (UTIs) are one of the most common infections encountered in clinical practice, many challenges remain with respect to classification and management. The purpose of this report is to discuss key issues in the management of UTIs and identify gaps in current knowledge and guidelines, as well as future research needs.

Design: A multidisciplinary panel of 13 experts from 6 European countries and the United States met on April 27, 2024. They discussed predefined key clinical questions, including classification of UTIs, current management guidelines, management of UTIs in men, antimicrobial switching, and post-treatment asymptomatic bacteriuria.

Results: The panel agreed that differentiation between complicated and uncomplicated UTIs is crucial to antimicrobial selection and can impact outcomes. In particular, definitions of complicated UTIs (cUTIs) vary widely between guidelines and in the literature. Patients with cUTIs are not a homogeneous group and differences in risk factors and prognosis should be considered. However, a balance must be sought between appropriate antimicrobial treatment and complexity of guidelines, which can hinder their implementation, especially in primary care. Guidelines published by the European Urology Association and the Infectious Diseases Society of America differ in their antimicrobial treatment recommendations for cUTIs, which is important at a time of increasing antimicrobial resistance. In men with UTIs, it has been established that a longer duration of antimicrobial therapy is needed in cases where fever is present. De-escalation from broad- to narrow-spectrum antimicrobials is recommended wherever possible, and is associated with similar outcomes in many patients relative to remaining on broad-spectrum treatment. Post-treatment asymptomatic bacteriuria should not be assessed, and treatment is not recommended. Non-specialist physician education is crucial to achieving better outcomes for patients with UTIs.

Implications: Many challenges remain in the management of UTIs in adults, most notably making an accurate classification, which drives antimicrobial treatment selection. A balance between adequacy of management guidelines and their uptake in routine clinical practice is needed to improve outcomes.

成人尿路感染:现行指南的差距-来自国际多学科小组的意见及其与临床实践的相关性
目的:虽然尿路感染是临床最常见的感染之一,但在分类和管理方面仍存在许多挑战。本报告的目的是讨论尿路感染管理中的关键问题,并确定当前知识和指南方面的差距,以及未来的研究需求。设计:由来自6个欧洲国家和美国的13名专家组成的多学科小组于2024年4月27日会面。他们讨论了预先确定的关键临床问题,包括尿路感染的分类、目前的管理指南、男性尿路感染的管理、抗菌药物切换和治疗后无症状细菌尿。结果:专家组一致认为,区分复杂和非复杂的尿路感染对抗菌药物的选择至关重要,并可能影响结果。特别是,复杂uti (cUTIs)的定义在指南和文献中差异很大。cuti患者不是一个同质的群体,应考虑危险因素和预后的差异。然而,必须在适当的抗菌药物治疗和指南的复杂性之间寻求平衡,因为指南的复杂性可能会阻碍其实施,特别是在初级保健中。欧洲泌尿外科协会和美国传染病学会发布的指南对cUTIs的抗菌治疗建议有所不同,这在抗菌药物耐药性日益增加的时代很重要。对于患有尿路感染的男性,已经确定,在出现发烧的情况下,需要更长时间的抗菌治疗。尽可能推荐从广谱抗菌素降为窄谱抗菌素,并且与继续使用广谱治疗相比,许多患者的结果相似。治疗后无症状菌尿不应评估,不建议治疗。非专科医师教育对于尿路感染患者获得更好的治疗效果至关重要。意义:在成人尿路感染的管理中仍然存在许多挑战,最值得注意的是进行准确的分类,这推动了抗菌治疗的选择。需要在管理指南的充分性和常规临床实践中对其的吸收之间取得平衡,以改善结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
BMC Proceedings
BMC Proceedings Biochemistry, Genetics and Molecular Biology-Biochemistry, Genetics and Molecular Biology (all)
CiteScore
3.50
自引率
0.00%
发文量
6
审稿时长
10 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信